Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Galmed Pharmaceuticals (NASDAQ:GLMD) through any online brokerage.
Other companies in Galmed Pharmaceuticals’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Dermata Therapeutics Inc (NASDAQ:DRMA), Geovax Labs Inc (NASDAQ:GOVX), CollPlant Biotechnologies Ltd (NASDAQ:CLGN) and AquaBounty Technologies Inc (NASDAQ:AQB).
Galmed Pharmaceuticals has a consensus price target of $4.00.
The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.6167 last updated May 8, 2026 at 7:31 PM EDT.
There are no upcoming dividends for Galmed Pharmaceuticals.
Galmed Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Galmed Pharmaceuticals.
Galmed Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.